Additionally, while FES PET can be used to help distinguish ER+ breast carcinoma metastasis from other malignancies, there are several other diseases that can be ER+ and the interpreting physician should familiarize themselves with the potential for mistaken identification. Here, ESR1 is linked to breast carcinoma.